Table 2.
Number of BMM Tests Ordered 1999–2005, by Type of Test and Location, Among Eligible* Medicare Beneficiaries
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | |
| Central DXAs | |||||||
| Nonfacility† | 678,960 | 771,600 | 842,160 | 922,160 | 947,280 | 978,640 | 999,020 |
| Facility† | 279,560 | 346,760 | 385,900 | 421,220 | 439,620 | 428,840 | 437,640 |
| Total | 958,520 | 1,118,360 | 1,228,060 | 1,343,380 | 1,386,900 | 1,407,480 | 1,436,660 |
| Peripheral DXAs | |||||||
| Nonfacility† | 72,040 | 54,740 | 43,240 | 38,220 | 30,980 | 27,200 | 21,000 |
| Facility† | 14,840 | 16,000 | 10,240 | 7,100 | 5,420 | 4,260 | 5,560 |
| Total | 86,880 | 70,740 | 53,480 | 45,320 | 36,400 | 31,460 | 26,560 |
| Any other BMM‡ | 42,540 | 37,780 | 37,980 | 32,980 | 60,120 | 55,900 | 54,660 |
* Eligible persons must have had 12 mo of Medicare Part A + Part B and be ≥65 yr of age at the end of the year in which the test was performed. These national estimates reflect data from the Medicare 5% sample.
† Nonfacility claims are those performed in settings such as a physician office. Facility claims are those performed in settings such as in the hospital or the outpatient radiology department of a hospital.
‡Other BMM includes QCT, single- and dual-photon absorptiometry, and ultrasound BMD measurements.